Showing results (1211-1220 of 1,351) with videos related to

Sort By:
Pageof 136
Oncotargets and Therapy|October 16, 2020
The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon AdenocarcinomaGuo-Tian Ruan, Yi-Zhen Gong, Li-Chen Zhu, et al.
Cell Death & Disease|February 21, 2024
HMGA1 drives chemoresistance in esophageal squamous cell carcinoma by suppressing ferroptosisJing-Yu Yang, Xin-Yuan Lei, Kai-Yue He, et al.
Stem Cell Reports|November 4, 2022
BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogrammingKenan Sevinç, Gülben Gürhan Sevinç, Ayşe Derya Cavga, et al.
Molecular Therapy. Oncology|April 15, 2025
Erratum: Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapyWei Ni, Swati Garg, Basudev Chowdhury, et al.
Environmental Science & Technology|March 2, 2022
Observational Insights into Isoprene Secondary Organic Aerosol Formation through the Epoxide Pathway at Three Urban Sites from Northern to Southern ChinaYu-Qing Zhang, Xiang Ding, Quan-Fu He, et al.
Science China. Life Sciences|June 9, 2025
N<sup>6</sup>-methyladenosine reader YTHDF3-mediated CEBPA translation maintains genomic stability and stem cell function to prevent liver injuryYaxu Liang, Weiwei Yu, Haifeng Sun, et al.
Neoplasia (New York, N.Y.)|June 9, 2021
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53Joanna S Yi, Oscar Sias-Garcia, Nicole Nasholm, et al.
Elife|November 16, 2018
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcomaGerard L Brien, David Remillard, Junwei Shi, et al.
Molecular Therapy. Oncology|March 24, 2025
Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDsWei Ni, Swati Garg, Basudev Chowdhury, et al.
Oncotarget|May 18, 2017
A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT)Xiaobing Wang, Xiuyi Zhi, Zhaogang Yang, et al.
Pageof 136